AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 81 min read$ATEX

DANIELS LESLIE B sold $880K of ATEX

DANIELS LESLIE B sold 10,100 shares of Anterix Inc. (ATEX) at an average of $87.12 ($86.50–$87.31, $0.88M total) across 3 trades over 2026-09-03 to 2026-09-04.

Original reporting
SEC EDGAR · DANIELS LESLIE B
Published Sep 8, 2026, 8:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 8, 2026, 8:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ATEX
Neutral
medium confidence
Mentioned
$ATEX
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATEXNeutralLow
01

Why it matters

The disclosed sale is modest and unlikely to move the stock significantly, but it adds to the flow of insider activity data.

02

Market read

New insider sale filing; low material impact but useful for monitoring insider sentiment.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 5/10Novelty 5/10Timing: filed today

Background

Form 4 filings provide transparent insight into insider trading activity; director sales are monitored by investors for sentiment cues.

Company-level read

Ticker impact

$ATEXNeutralMedium confidence
Context

Director Leslie B. Daniels sold approximately $880K of ATEX shares via open‑market transactions on Sep 3‑4, reducing his stake to 45,977 shares.

Expected impact

Minor downward pressure, likely within normal trading variance.

Evidence & confidence

Form 4 is a primary disclosure; size under $1M and director role suggest low materiality.

Market effects

Sector

No broader sector impact; insider sale is company‑specific.

Regional

U.S. market only; negligible regional effect.

Global

Not globally relevant.

Counterpoint

What could challenge this read

The sale could be a routine liquidity move rather than a negative signal.

Key entities

  • Company
    Anterix Inc.

    U.S. listed communications infrastructure firm (NASDAQ: ATEX).

  • Individual
    Leslie B. Daniels

    Director of Anterix Inc. who sold shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ATEX insider trading history →

Related articles

SEP 7
$ATEXMed

Is Anterix (ATEX) Quietly Reframing Its Connectivity Moat With New 900 MHz FCC Flexibility?

Anterix (ATEX) gained attention after the FCC approved expanded 900 MHz broadband use and granted it a license for satellite testing. This could broaden its network applications and reinforce its investment narrative, though profitability currently relies heavily on noncash spectrum gains. Analysts project $6.9M revenue and $935K earnings by 2028, with a potential 36% downside from current prices.

simplywall.st2 min
AUG 19
$ATEXMed

Anterix (ATEX) Q1 2027 Earnings Call Transcript

Anterix (ATEX) reported Q1 2027 revenue of $2M, up from $1.4M YoY, with net income of $240K. Operating expenses decreased to $12.9M. The company has $116M in cash, no debt, and $226.7M left for share repurchases. Management highlighted 12 active deals, spectrum clearing progress, and support for SpaceX's FCC proposal. CFO warned of potential higher costs if spectrum clearing is accelerated.

fool.com4 min
AUG 11
$ATEXMed

Anterix Inc. (ATEX): Results of Operations and Financial Condition

Anterix Inc. (ATEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Anterix Inc. Reports First Quarter Fiscal Year 2027 Results Woodland Park, NJ – August 11, 2026 – Anterix (NASDAQ: ATEX) today announced its first quarter fiscal 2027 results and filed its Form 10-Q for the three months ended June 30, 2026. Financial and Operational Highlights –

SEC EDGAR 8-K6 min
JUN 10
$ATEXMed

Anterix Inc. (ATEX): Results of Operations and Financial Condition

Anterix Inc. (ATEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 atex-20260331xpressrelease.htm EX-99.1 Document Anterix Inc. Reports Full Fiscal Year 2026 Results Woodland Park, NJ – June 10, 2026 – Anterix (NASDAQ: ATEX) today announced fiscal 2026 fourth quarter and full fiscal year financial results for the year ended March 31, 2

SEC EDGAR 8-K6 min
SEP 17
$XBPLow

Avenue RP Opportunities Fund, L.P. (LASRY MARC) purchased $1.5M of XBP (indirect holdings)

Avenue RP Opportunities Fund, L.P. purchased 527,606 indirectly-held shares of XBP Global Holdings, Inc. (XBP) at $2.83 ($1.49M total) across 2 trades on 2026-09-15. Filed jointly with Avenue Global Dislocation Opportunities Fund, L.P. (10% owner), Avenue Europe International Management, L.P. (10% owner), Avenue Capital Management II, L.P. (10% owner), Avenue RP Opportunities Fund GenPar, LLC (10% owner), Avenue Global Dislocation Opportunities GenPar, LLC (10% owner), GL RP Partners, LLC (10% owner), GL Global Dislocation Opportunities Partners, LLC (10% owner) and LASRY MARC (10% owner).

SEC EDGAR1 min